LifeTech Scientific Corp

81X

Company Profile

  • Business description

    LifeTech Scientific Corp develops and manufactures also responsible for marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: the Structural heart diseases business, the Peripheral vascular diseases business, and the Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral Vascular Diseases business segment. Geographically, it derives a majority of its revenue from Mainland China, and it also has its presence in Europe, Asia, excluding mainland China and India, India, South America, Africa, and Others.

  • Contact

    No. 22, Keji 12th Road South
    14th Floor, LifeTech Scientific Building
    High-tech Industrial Park
    Nanshan District
    Shenzhen518063
    CHN

    T: +86 75586026250

    http://www.lifetechmed.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    1,240

Stocks News & Analysis

stocks

OpenAI is going public as the worst value among its peers

Investors are paying a steep price relative to the underlying business quality, PitchBook research says.
stocks

Wide moat healthcare leader remains undervalued

ASX healthcare giant expected to see uptick in demand from emerging markets.
stocks

This US AI winner has been unstoppable. Is it time to sell?

Astonishing results have driven this AI stock into significantly overvalued territory.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,855.9079.60-0.89%
CAC 408,218.2426.05-0.32%
DAX 4024,759.05185.90-0.75%
Dow JONES (US)50,883.81678.12-1.32%
FTSE 10010,368.057.730.07%
HKSE24,961.95291.45-1.15%
NASDAQ25,762.991,067.96-3.98%
Nikkei 22566,588.12882.57-1.31%
NZX 50 Index13,161.9760.360.46%
S&P 5007,391.12193.19-2.55%
S&P/ASX 2008,625.1080.00-0.92%
SSE Composite Index4,027.7430.04-0.74%

Market Movers